Spots Global Cancer Trial Database for cmr
Every month we try and update this database with for cmr cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP) | NCT01570868 | Leukemia | Ponatinib | 18 Years - | M.D. Anderson Cancer Center | |
Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP) | NCT01570868 | Leukemia | Ponatinib | 18 Years - | M.D. Anderson Cancer Center | |
Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR | NCT04461223 | Cardiotoxicity Osteosarcoma Myocardial Inju... Chemotherapy In... Doxorubicin Ind... | contrast-enhanc... | 8 Years - 50 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP) | NCT01570868 | Leukemia | Ponatinib | 18 Years - | M.D. Anderson Cancer Center | |
Early Detection of Cardiac Damage With CMR in Women With Breast Cancer | NCT04046315 | Cardiotoxicity Breast Cancer Chemotherapy In... | CMR | 18 Years - | Radboud University Medical Center |